Embryonic Stem Cell Research Not Dead Yet Despite Geron Pullout | LifeNews.com: ESC’s are taken from embryos that are destroyed in the process, with the hopes that the biotech company can patent a successful line of cells and perpetuate that line of cells indefinitely in the laboratory. With a perpetually growing and dividing line of cells, it is thought, therapy will be less expensive than the more labor-intensive process of retrieval and processing of the patient’s own cells. That’s a powerful business model for modern day gold prospectors, and one that will keep ESC’s in the game for quite some time to come.
'via Blog this'
No comments:
Post a Comment